Tag Archives: ALXN

Alexion Pharmaceuticals Got Some Good News

Morgan Stanley analyst Matthew Harrison upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) to Buy today. The company’s shares closed yesterday at $101.08, close to its 52-week low of $98.63. According to TipRanks.com, Harrison is a 4-star analyst with an average return of

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alexion Pharmaceuticals (NASDAQ: ALXN) and Anavex Life Sciences (NASDAQ: AVXL)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (NASDAQ: ALXN) and Anavex Life Sciences (NASDAQ: AVXL). Alexion Pharmaceuticals (NASDAQ: ALXN) In a report released today, Anupam Rama from J.P.

Alexion Pharmaceuticals was Downgraded to a Hold Rating at J.P. Morgan

J.P. Morgan analyst Anupam Rama downgraded Alexion Pharmaceuticals (NASDAQ: ALXN) to Hold today. The company’s shares opened today at $111.41, close to its 52-week low of $102.47. According to TipRanks.com, Rama is a 1-star analyst with an average return of

Analysts Are Bullish on These Healthcare Stocks: ALXN, LBIO

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alexion Pharmaceuticals (NASDAQ: ALXN) and Lion Biotechnologies Inc (NASDAQ: LBIO) with bullish sentiments. Alexion Pharmaceuticals (NASDAQ: ALXN) Cowen & Co. analyst Eric

Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR). Alexion Pharmaceuticals (NASDAQ: ALXN) In a report released yesterday,

Oppenheimer Gives a Hold Rating to Alexion Pharmaceuticals

In a report released yesterday, Hartaj Singh from Oppenheimer reiterated a Hold rating on Alexion Pharmaceuticals (NASDAQ: ALXN). The company’s shares closed yesterday at $130.39. Singh noted: “Alexion (ALXN) reported 4Q16 earnings and provided 2017 guidance that was in line